No charge to UT faculty, UT staff, residents, or students.
Friday, October 9, 2020 Program begins at 7:30am
Saturday, October 10, 2020 Program begins at 9:30am
Meeting Location
Zoom WebinarThe link will be sent approximately one week before the meeting.
Learning Objectives
Explain how artificial intelligence (AI) can be used for the future of medicine and ophthalmology
Examine preclinical studies on glaucoma therapies and explain them
Assess if biofilms have the ability to complicate the outcome of corneal infections
Understand the role of genetics in determining mechanisms of ocular disease and the creation of new treatments,
specifically for glaucomaAssess how digital health will improve the field of ophthalmology
Describe the importance of ophthalmic drug regulation
Identify the role of the FDA in innovation for vision care Describe DMEK and Bowman layer transplantation
Examine technological innovations to address vision rehabilitation in AMD patients
Explain the traps and pitfalls in the evaluation of innovations
Compare the current treatment of presbyopia to what is being developed for its future treatment
Explain the current understanding of how vision changes during space travel
8 hours of CME Credit Available